News
04-25-2012, 11:06 AM
Researchers from the Bellvitge Biomedical Research Institute (IDIBELL) have shown that overactivation of the RANK signalling pathway promotes the initiation, progression and metastasis of tumours in human breast epithelial cells by dedifferentiation of breast cells to stem cells. The results of this study have been advanced in the electronic edition of the journal Cancer Research.
More... (http://www.news-medical.net/news/20120425/RANK-inhibitor-chemotherapy-combination-may-have-important-therapeutic-effects-against-breast-cancer.aspx)
More... (http://www.news-medical.net/news/20120425/RANK-inhibitor-chemotherapy-combination-may-have-important-therapeutic-effects-against-breast-cancer.aspx)